Effects of metformin+sitagliptin versus metformin + glibenclamide combinations on lipid profile, body mass index and kidney function in Iraqi patients with type 2 diabetes mellitus.

Until 1995, only two options for pharmacologic treatment were available for patients with diabetes; sulfonylurea (for type 2 DM only) and insulin (for type 1 or 2). Since 1995, a number of new oral agents, injectables, and insulins have been introduced in therapy. Currently, six classes of oral age...

Full description

Bibliographic Details
Main Authors: Hassan Mohammed Abbas Al-Temimi, Kassim Al-Shamma, Salim AlRubaie
Format: Article
Language:English
Published: College of Pharmacy / Mustansiriyah University 2013-06-01
Series:Al-Mustansiriyah Journal of Pharmaceutical Sciences
Subjects:
Online Access:https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/190